Skip to content

menu

Health Law Pulse logo
HomeAboutContact
Search
Close
RegulatoryEnforcementFDA & Food SafetyTransparencyInternational
View topics Archives
Subscribe

Health Law Pulse

Leading insight on legal developments in the healthcare and life sciences industries.

drug pricing

Subscribe to drug pricing via RSS

COVID-19 Update: Trump Issues ‘Buy American’ Executive Order Related to Drugs

Photo of Yvonne Puig (US)Photo of Daphne Calderon (US)Photo of Jeff Wurzburg (US)
By Yvonne Puig (US), Daphne Calderon (US) & Jeff Wurzburg (US) on August 7, 2020

On August 6, 2020 President Trump signed an Executive Order on Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs are Made in the United States.  The Executive Order states that “the domestic supply chains must be capable of meeting…

President Trump unveils executive orders on lowering drug prices

Photo of Mark Faccenda (US)Photo of Jeff Wurzburg (US)Photo of Hayley White (US)
By Mark Faccenda (US), Jeff Wurzburg (US) & Hayley White (US) on July 30, 2020

On Friday, July 24, 2020, President Trump issued three executive orders, and announced a potential fourth executive order, with the stated intention of lowering the cost of prescription drugs in the United States. The general consensus among legal commentators is…

Subscribe to Health Law Pulse

Subscribe to this publication

Recent effort to regulate pharmaceutical pricing deemed unconstitutional by Fourth Circuit

Photo of Robin Adelstein (US)
By Robin Adelstein (US) on April 17, 2018

In the absence of federal action, states have attempted to rein in high pharmaceutical pricing by enacting laws aimed at regulating drug pricing. Following what now has become a trend, on March 13, 2018, Oregon became the newest state to…

How pharma cos. can shape the drug-pricing landscape

Photo of Robin Adelstein (US)
By Robin Adelstein (US) on January 25, 2017

Unless you have been living under a rock, you no doubt have noticed that drug price increases have resulted in a wave of public criticism, playing right into the media’s demonization of the pharmaceutical industry, and even becoming an election…

Health Law Pulse

Facebook Twitter RSS LinkedIn YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date on healthcare enforcement and regulations with the Health Law Pulse. We give you the news and analysis that matter to your business in a quick, easy-to-read format.

Read more

Topics

Archives

Copyright © 2026, Norton Rose Fulbright LLP. All rights reserved.